D037282Chemicals & DrugsD12.644.360.381.374D12.776.157.125.412.374D12.776.476.387.374D12.776.503.303Calreticulinprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfConnectionsnumber of connectionsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierInformation Resourcevivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConcept32694616Ok CY, Trowell KT, Parker KG, Moser K, Weinberg OK, Rogers HJ, Reichard KK, George TI, Hsi ED, Bueso-Ramos CE, Tam W, Orazi A, Bagg A, Arber DA, Hasserjian RP, Wang SAModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncOk CY, Trowell KT, Parker KG, Moser K, Weinberg OK, Rogers HJ, Reichard KK, George TI, Hsi ED, Bueso-Ramos CE, Tam W, Orazi A, Bagg A, Arber DA, Hasserjian RP, Wang SA. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Mod Pathol. 2021 Jan; 34(1):20-31.Mod Pathol2020-07-21T00:00:002020Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1.30105753Xia D, Hsi ED, Dal Cin P, Hasserjian RPAmerican journal of hematologyXia D, Hsi ED, Dal Cin P, Hasserjian RP. Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation. Am J Hematol. 2019 Apr; 94(4):504-505.Am J Hematol2018-09-21T00:00:002018Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation.27686170Nomani L, Bodo J, Zhao X, Durkin L, Loghavi S, Hsi EDAmerican journal of clinical pathologyNomani L, Bodo J, Zhao X, Durkin L, Loghavi S, Hsi ED. CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms. Am J Clin Pathol. 2016 Oct; 146(4):431-8.Am J Clin Pathol2016-10-01T00:00:002016CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms.27258562Sakr H, Clark Schneider K, Murugesan G, Bodo J, Hsi ED, Cook JRApplied immunohistochemistry & molecular morphology : AIMMSakr H, Clark Schneider K, Murugesan G, Bodo J, Hsi ED, Cook JR. pSTAT3/pSTAT5 Signaling Patterns in Molecularly Defined Subsets of Myeloproliferative Neoplasms. Appl Immunohistochem Mol Morphol. 2018 Feb; 26(2):147-152.Appl Immunohistochem Mol Morphol2018-02-01T00:00:002018pSTAT3/pSTAT5 Signaling Patterns in Molecularly Defined Subsets of Myeloproliferative Neoplasms.18689689Park YJ, Liu G, Lorne EF, Zhao X, Wang J, Tsuruta Y, Zmijewski J, Abraham EProceedings of the National Academy of Sciences of the United States of AmericaPark YJ, Liu G, Lorne EF, Zhao X, Wang J, Tsuruta Y, Zmijewski J, Abraham E. PAI-1 inhibits neutrophil efferocytosis. Proc Natl Acad Sci U S A. 2008 Aug 19; 105(33):11784-9.Proc Natl Acad Sci U S A2008-08-08T00:00:002008PAI-1 inhibits neutrophil efferocytosis.0.7787060.08502795subject area for